Research Summary
The influenza vaccine is a preventive vaccine designed to protect against acute respiratory infections caused by influenza viruses. It works by introducing inactivated or attenuated viral components or proteins into the body, stimulating the immune system to produce specific antibodies that help defend against infection when exposed to the virus. Since influenza strains can mutate annually, the World Health Organization regularly updates vaccine formulations to match circulating strains. Receiving the influenza vaccine significantly reduces the risk of infection, lessens the severity of illness, and lowers the incidence of complications and hospitalizations, making it especially recommended for high-risk groups such as the elderly, children, pregnant women, and individuals with chronic conditions.
According to WENKH research statistics, the global Influenza Vaccine market size will reach 11,097 Million USD in 2026 and is projected to reach 16,359 Million USD by 2033, with a CAGR of 5.70% (2026-2033). Among them, the Asia-Pacific Influenza Vaccine market is undergoing rapid changes, reaching Million USD in 2026, accounting for approximately % of the global market share. It is projected to reach Million USD by 2033.
The global Influenza Vaccine market is characterized by a highly consolidated structure in developed regions and increasingly fragmented competition in emerging markets. In North America and Europe, major pharmaceutical companies such as Sanofi, CSL, GlaxoSmithKline, Viatris, and AstraZeneca dominate market share with well-established distribution networks and advanced manufacturing capabilities. Sanofi and CSL remain at the forefront, leveraging strong pipelines and extensive regulatory experience. Sanofi continues to benefit from its quadrivalent influenza vaccine portfolio, while CSL’s Seqirus unit maintains a competitive edge through its cell-based and adjuvanted formulations, which are gaining traction for their enhanced efficacy. GlaxoSmithKline maintains a notable presence through strategic procurement contracts and seasonal product launches, while Viatris and AstraZeneca contribute with a focus on intranasal delivery platforms and cost-effective vaccine solutions.
The competitive landscape in Asia is more diversified and dynamic, driven by the presence of regional players and growing domestic demand. Chinese manufacturers such as Hualan Biological Engineering, Changchun Institute of Biological Products, Sinovac Biotech, BCHT Biotechnology, and Jiangsu GDK Biotechnology are actively expanding production capacity and accelerating research in response to public health initiatives. Sinovac and Hualan Bio have established themselves as leading suppliers to national immunization programs, with product lines tailored for both public procurement and private distribution. BCHT and Changchun Institute of Biological Products are also enhancing competitiveness by investing in next-generation vaccine technologies. In Japan, KM Biologics plays a significant role, supported by strong governmental backing and domestic trust in locally produced vaccines.
The global Influenza Vaccine market is highly competitive, with key market players including Sanofi, CSL, GSK, Viatris, AstraZeneca, Hualan Bio, Changchun Institute of Biological, Sinovac, BCHT, Jiangsu GDK, KM Biologics, etc. This report categorizes the competitive landscape of the global Influenza Vaccine market into three tiers based on annual revenue, with the top three market players holding approximately % of the total market share.
This report provides an in-depth analysis of the global Influenza Vaccine market, including market size, price trends, market status and future development prospects. It particularly focuses on the market share, product characteristics, pricing, sales revenue, and gross profit margin of major players in the global Influenza Vaccine industry. Additionally, this report provides an in-depth analysis of the market status and future development trends of different product segments of Influenza Vaccine and their downstream application fields.
In terms of data, this report includes a comprehensive time-series dataset. The historical data spans from 2021 to 2025, providing a solid foundation for analyzing past market trends. The year 2026 is used as a base year to accurately assess the current market landscape. Forecast data covers the period from 2027 to 2033, utilizing scientific analysis methods and models to offer forward-looking predictions and insights into the market's future development. This provides valuable reference information for industry participants and stakeholders.
The report covers regions and countries including North America, Europe, China, Asia Pacific (excluding China), Latin America, the Middle East, and Africa. It particularly focuses on the sales revenue of Influenza Vaccine in these regions and countries, as well as the market share of key market players in each region. The report provides an in-depth analysis of the regional distribution and future development trends of the Influenza Vaccine market. By considering local policies, this report evaluates the market prospects of Influenza Vaccine in each region and country, aiming to help companies gain a comprehensive understanding of the industry characteristics and development potential in different regions, optimize regional business layout, and develop precise market strategies to achieve global development goals.
This report places a strong emphasis on data quality and reliability, utilizing diverse and extensive data sources to ensure the accuracy and validity of the information presented. Primary data collection involves multiple channels, including in-depth interviews with senior executives, industry experts, supply chain stakeholders, and end consumers. These interviews provide key insights into corporate strategic planning, industry policy interpretation, supply chain dynamics, and end-user experiences. Secondary data sources cover a wide range of authoritative statistics from government agencies, customs databases, industry associations, third-party paid databases, brokerage research reports, academic research findings, corporate annual reports, financial statements, real-time news updates, and relevant information from international organizations. These data sources serve as a solid foundation for verification and analysis.
Companies Covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Product Segment
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Product Application
6 Months to 3 Years
＞ 3 Years
Chapter Scope
Chapter 1: Product Statistical Scope, Product Segmentation Types and Downstream Applications, Overall Market Size, Current Status and Development Prospects
Chapter 2: Global Influenza Vaccine Industry Chain Analysis
Chapter 3: Global Influenza Vaccine Industry Environment Analysis and Porter's Five Forces Analysis
Chapter 4: Analysis of the Competitive Landscape of Major Companies in the Global Influenza Vaccine Market (Market Share, Product Revenue Comparison, Tier Division, Corporate Expansion and M&A Trends)
Chapter 5: Analysis of Global Major Companies (Company Profiles, Product Features and Product Segment, Product Revenue, Product Average Price, Gross Profit Margin and Geographical Sales Share)
Chapter 6: Global Influenza Vaccine Product Segment and Downstream Application Size Analysis and Major Regional Market Size Analysis
Chapter 7: North America Influenza Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 8: Europe Influenza Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 9: China Influenza Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 10: Asia Pacific (excluding China) Influenza Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 11: Latin America Influenza Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 12: Middle East and Africa Influenza Vaccine Product Segment, Downstream Application, and Major Countries Market Size Analysis
Chapter 13: Research Conclusion
Chapter 14: Methodology and Data Source
Purpose and Value of the Report
Market Trend Insights: Analyze industry trends, market dynamics, and future growth potential to help companies forecast changes and develop strategic plans.
Competitive Landscape Analysis: Understand key players' revenue segmentation, strategies, market share, and business models to guide competitive decisions.
Investment Decision Support: Provide feasibility analysis through market size, growth rate, demand trends, and potential risks for informed investment decisions.
Target Customer and Demand Analysis: Examine consumer behavior, purchasing preferences, and pain points to optimize products and improve market penetration.
Policy and Regulatory Insights: Interpret relevant industry policies to ensure compliance and mitigate regulatory risks.
Business Model Optimization: Offer data-driven suggestions for enhancing business models and improving profitability.
Table of Contents
1 Influenza Vaccine Market Overview
1.1 Product Definition Introduction
1.2 Global Influenza Vaccine Market Size and Growth Forecast Analysis (2021-2033)
1.3 Influenza Vaccine Market Status and Development Prospects
1.3.1 Influenza Vaccine Market Status
1.3.2 Influenza Vaccine Industry Development Prospects
1.4 Influenza Vaccine Market Overview by Product Segment
1.4.1 Global Influenza Vaccine Market Size and Growth Forecast Analysis by Product Segment: 2021 VS 2026 VS 2033
1.4.2 Trivalent Influenza Vaccine
1.4.3 Quadrivalent Influenza Vaccine
1.5 Influenza Vaccine Market Overview by Product Application
1.5.1 Global Influenza Vaccine Market Size and Growth Forecast Analysis by Product Application: 2021 VS 2026 VS 2033
1.5.2 6 Months to 3 Years
1.5.3 ＞ 3 Years
2 Influenza Vaccine Industry Supply Chain Analysis
2.1 Influenza Vaccine Supply Chain
2.2 Influenza Vaccine Midstream Suppliers
2.3 Influenza Vaccine Downstream Customers
2.4 Influenza Vaccine Sales Channel Analysis
3 Influenza Vaccine Market Environment Analysis
3.1 Influenza Vaccine Industry Policy Analysis
3.2 Influenza Vaccine Emerging Technology Trends in the Industry
3.3 Influenza Vaccine Restraining Factors Analysis
3.4 Influenza Vaccine Market Porter's Five Forces Analysis
3.4.1 Competitive Rivalry
3.4.2 Threat of New Entrants
3.4.3 Bargaining Power of Suppliers
3.4.4 Bargaining Power of Buyers
3.4.5 Threat of Substitute Products or Services
4 Global Influenza Vaccine Market Players Competition Landscape
4.1 Global Influenza Vaccine Market Revenue by Key Players (2021-2026)
4.2 Global Influenza Vaccine Market Position by Key Players
4.3 Global Key Players Headquarter and Key Area Served
4.4 Global Influenza Vaccine Market Expansion and M&A Dynamic
5 In-depth Analysis of Key Players
5.1 Sanofi
5.1.1 Sanofi Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.1.2 Sanofi Influenza Vaccine Product Features
5.1.3 Sanofi Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.1.4 Sanofi Influenza Vaccine Revenue by Product Segment
5.1.5 Sanofi Influenza Vaccine Revenue by Region
5.2 CSL
5.2.1 CSL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.2.2 CSL Influenza Vaccine Product Features
5.2.3 CSL Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.2.4 CSL Influenza Vaccine Revenue by Product Segment
5.2.5 CSL Influenza Vaccine Revenue by Region
5.3 GSK
5.3.1 GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.3.2 GSK Influenza Vaccine Product Features
5.3.3 GSK Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.3.4 GSK Influenza Vaccine Revenue by Product Segment
5.3.5 GSK Influenza Vaccine Revenue by Region
5.4 Viatris
5.4.1 Viatris Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.4.2 Viatris Influenza Vaccine Product Features
5.4.3 Viatris Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.4.4 Viatris Influenza Vaccine Revenue by Product Segment
5.4.5 Viatris Influenza Vaccine Revenue by Region
5.5 AstraZeneca
5.5.1 AstraZeneca Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.5.2 AstraZeneca Influenza Vaccine Product Features
5.5.3 AstraZeneca Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.5.4 AstraZeneca Influenza Vaccine Revenue by Product Segment
5.5.5 AstraZeneca Influenza Vaccine Revenue by Region
5.6 Hualan Bio
5.6.1 Hualan Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.6.2 Hualan Bio Influenza Vaccine Product Features
5.6.3 Hualan Bio Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.6.4 Hualan Bio Influenza Vaccine Revenue by Product Segment
5.6.5 Hualan Bio Influenza Vaccine Revenue by Region
5.7 Changchun Institute of Biological
5.7.1 Changchun Institute of Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.7.2 Changchun Institute of Biological Influenza Vaccine Product Features
5.7.3 Changchun Institute of Biological Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.7.4 Changchun Institute of Biological Influenza Vaccine Revenue by Product Segment
5.7.5 Changchun Institute of Biological Influenza Vaccine Revenue by Region
5.8 Sinovac
5.8.1 Sinovac Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.8.2 Sinovac Influenza Vaccine Product Features
5.8.3 Sinovac Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.8.4 Sinovac Influenza Vaccine Revenue by Product Segment
5.8.5 Sinovac Influenza Vaccine Revenue by Region
5.9 BCHT
5.9.1 BCHT Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.9.2 BCHT Influenza Vaccine Product Features
5.9.3 BCHT Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.9.4 BCHT Influenza Vaccine Revenue by Product Segment
5.9.5 BCHT Influenza Vaccine Revenue by Region
5.10 Jiangsu GDK
5.10.1 Jiangsu GDK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.10.2 Jiangsu GDK Influenza Vaccine Product Features
5.10.3 Jiangsu GDK Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.10.4 Jiangsu GDK Influenza Vaccine Revenue by Product Segment
5.10.5 Jiangsu GDK Influenza Vaccine Revenue by Region
5.11 KM Biologics
5.11.1 KM Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
5.11.2 KM Biologics Influenza Vaccine Product Features
5.11.3 KM Biologics Influenza Vaccine Product Revenue and Gross Margin Analysis (2021-2026)
5.11.4 KM Biologics Influenza Vaccine Revenue by Product Segment
5.11.5 KM Biologics Influenza Vaccine Revenue by Region
6 Global Influenza Vaccine Market Analysis by Regions, by Product Segment and Application
6.1 Global Influenza Vaccine Market Size and Growth Forecast by Region: 2021 VS 2026 VS 2033
6.1.1 Global Influenza Vaccine Market Revenue by Region (2021-2026)
6.1.2 Global Influenza Vaccine Market Revenue Forecast by Region (2027-2033)
6.2 Global Influenza Vaccine Market Size by Product Segment (2021-2033)
6.3 Global Influenza Vaccine Market Size by Product Application (2021-2033)
7 North America Influenza Vaccine Market Analysis
7.1 North America Influenza Vaccine Market Prospects
7.1.1 North America Influenza Vaccine Market Revenue and Growth Forecast by Countries (2021-2033)
7.1.2 U.S.
7.1.3 Canada
7.2 North America Influenza Vaccine Market Size by Product Segment (2021-2033)
7.3 North America Influenza Vaccine Market Size by Product Application (2021-2033)
8 Europe Influenza Vaccine Market Analysis
8.1 Europe Influenza Vaccine Market Prospects
8.1.1 Europe Influenza Vaccine Market Revenue and Growth Forecast by Countries (2021-2033)
8.1.2 Germany
8.1.3 France
8.1.4 United Kingdom
8.1.5 Italy
8.1.6 Spain
8.1.7 Benelux
8.2 Europe Influenza Vaccine Market Size by Product Segment (2021-2033)
8.3 Europe Influenza Vaccine Market Size by Product Application (2021-2033)
9 China Influenza Vaccine Market Analysis
9.1 China Influenza Vaccine Market Prospects
9.2 China Influenza Vaccine Market Size by Product Segment (2021-2033)
9.3 China Influenza Vaccine Market Size by Product Application (2021-2033)
10 Asia Pacific (excl. China) Influenza Vaccine Market Analysis
10.1 Asia Pacific (excl. China) Influenza Vaccine Market Prospects
10.1.1 Asia Pacific (excl. China) Influenza Vaccine Revenue and Growth Forecast by Countries (2021-2033)
10.1.2 Japan
10.1.3 South Korea
10.1.4 India
10.1.5 Southeast Asia
10.1.6 Australia
10.2 Asia Pacific (excl. China) Influenza Vaccine Market Size by Product Segment (2021-2033)
10.3 Asia Pacific (excl. China) Influenza Vaccine Market Size by Product Application (2021-2033)
11 Latin America Influenza Vaccine Market Analysis
11.1 Latin America Influenza Vaccine Market Prospects
11.1.1 Latin America Influenza Vaccine Revenue and Growth Forecast by Countries (2021-2033)
11.1.2 Mexico
11.1.3 Brazil
11.2 Latin America Influenza Vaccine Market Size by Product Segment (2021-2033)
11.3 Latin America Influenza Vaccine Market Size by Product Application (2021-2033)
12 Middle East and Africa Influenza Vaccine Market Analysis
12.1 Middle East and Africa Influenza Vaccine Market Prospects
12.1.1 Middle East and Africa Influenza Vaccine Revenue and Growth Forecast by Countries (2021-2033)
12.1.2 Saudi Arabia
12.1.3 South Africa
12.2 Middle East and Africa Influenza Vaccine Market Size by Product Segment (2021-2033)
12.3 Middle East and Africa Influenza Vaccine Market Size by Product Application (2021-2033)
13 Research Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.2 Research Landscape
14.3 Research Benchmark and Hypothesis
14.4 Data Source
14.4.1 Primary Sources
14.4.2 Secondary Sources
14.5 Data Cross Validation
14.6 Disclaimer
Table 1：Global Influenza Vaccine Market Size and Growth Forecast Analysis by Product Segment (2021 VS 2026 VS 2033) & (Million USD)
Table 2：Global Influenza Vaccine Market Size and Growth Forecast Analysis by Product Application (2021 VS 2026 VS 2033) & (Million USD)
Table 3：Influenza Vaccine Downstream Customers List
Table 4：Influenza Vaccine Distributors/Dealers List
Table 5：Global Influenza Vaccine Market Revenue by Key Players (2021-2026) & (Million USD)
Table 6：Global Influenza Vaccine Market Position by Key Players
Table 7：Global Key Players Headquarter and Key Area Served
Table 8：Global Influenza Vaccine Market Expansion and M&A Dynamic
Table 9：Sanofi Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 10：Sanofi Influenza Vaccine Product Features
Table 11：Sanofi Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 12：Sanofi Influenza Vaccine Revenue by Product Segment
Table 13：Sanofi Influenza Vaccine Revenue by Region
Table 14：CSL Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 15：CSL Influenza Vaccine Product Features
Table 16：CSL Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 17：CSL Influenza Vaccine Revenue by Product Segment
Table 18：CSL Influenza Vaccine Revenue by Region
Table 19：GSK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 20：GSK Influenza Vaccine Product Features
Table 21：GSK Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 22：GSK Influenza Vaccine Revenue by Product Segment
Table 23：GSK Influenza Vaccine Revenue by Region
Table 24：Viatris Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 25：Viatris Influenza Vaccine Product Features
Table 26：Viatris Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 27：Viatris Influenza Vaccine Revenue by Product Segment
Table 28：Viatris Influenza Vaccine Revenue by Region
Table 29：AstraZeneca Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 30：AstraZeneca Influenza Vaccine Product Features
Table 31：AstraZeneca Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 32：AstraZeneca Influenza Vaccine Revenue by Product Segment
Table 33：AstraZeneca Influenza Vaccine Revenue by Region
Table 34：Hualan Bio Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 35：Hualan Bio Influenza Vaccine Product Features
Table 36：Hualan Bio Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 37：Hualan Bio Influenza Vaccine Revenue by Product Segment
Table 38：Hualan Bio Influenza Vaccine Revenue by Region
Table 39：Changchun Institute of Biological Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 40：Changchun Institute of Biological Influenza Vaccine Product Features
Table 41：Changchun Institute of Biological Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 42：Changchun Institute of Biological Influenza Vaccine Revenue by Product Segment
Table 43：Changchun Institute of Biological Influenza Vaccine Revenue by Region
Table 44：Sinovac Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 45：Sinovac Influenza Vaccine Product Features
Table 46：Sinovac Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 47：Sinovac Influenza Vaccine Revenue by Product Segment
Table 48：Sinovac Influenza Vaccine Revenue by Region
Table 49：BCHT Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 50：BCHT Influenza Vaccine Product Features
Table 51：BCHT Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 52：BCHT Influenza Vaccine Revenue by Product Segment
Table 53：BCHT Influenza Vaccine Revenue by Region
Table 54：Jiangsu GDK Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 55：Jiangsu GDK Influenza Vaccine Product Features
Table 56：Jiangsu GDK Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 57：Jiangsu GDK Influenza Vaccine Revenue by Product Segment
Table 58：Jiangsu GDK Influenza Vaccine Revenue by Region
Table 59：KM Biologics Basic Information (Total Revenue, Employees, Main Business, Service Area and Contact Information)
Table 60：KM Biologics Influenza Vaccine Product Features
Table 61：KM Biologics Influenza Vaccine Revenue (Million USD) and Gross Margin (2021-2026)
Table 62：KM Biologics Influenza Vaccine Revenue by Product Segment
Table 63：KM Biologics Influenza Vaccine Revenue by Region
Table 64：Global Influenza Vaccine Market Size and Growth Forecast by Region (2021 VS 2026 VS 2033) & (Million USD)
Table 65：Global Influenza Vaccine Market Revenue by Region (2021-2026) & (Million USD)
Table 66：Global Influenza Vaccine Market Share by Region (2021-2026)
Table 67：Global Influenza Vaccine Market Revenue Forecast by Region (2027-2033) & (Million USD)
Table 68：Global Influenza Vaccine Market Share Forecast by Region (2027-2033)
Table 69：Global Influenza Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 70：Global Influenza Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 71：Global Influenza Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)
Table 72：Global Influenza Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 73：North America Influenza Vaccine Market Revenue by Countries (2021-2026) & (Million USD)
Table 74：North AmericaInfluenza Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 75：North America Influenza Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 76：North America Influenza Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 77：North America Influenza Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)
Table 78：North America Influenza Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 79：Europe Influenza Vaccine Market Revenue by Countries (2021-2026) & (Million USD)
Table 80：Europe Influenza Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 81：Europe Influenza Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 82：Europe Influenza Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 83：Europe Influenza Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)
Table 84：Europe Influenza Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 85：China Influenza Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 86：China Influenza Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 87：China Influenza Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)
Table 88：China Influenza Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 89：Asia Pacific (excl. China) Influenza Vaccine Market Revenue by Countries (2021-2026) & (Million USD)
Table 90：Asia Pacific (excl. China) Influenza Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 91：Asia Pacific (excl. China) Influenza Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 92：Asia Pacific (excl. China) Influenza Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 93：Asia Pacific (excl. China) Influenza Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)
Table 94：Asia Pacific (excl. China) Influenza Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 95：Latin America Influenza Vaccine Market Revenue by Countries (2021-2026) & (Million USD)
Table 96：Latin America Influenza Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 97：Latin America Influenza Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 98：Latin America Influenza Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 99：Latin America Influenza Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)
Table 100：Latin America Influenza Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 101：Middle East and Africa Influenza Vaccine Market Revenue by Countries (2021-2026) & (Million USD)
Table 102：Middle East and Africa Influenza Vaccine Market Revenue Forecast by Countries (2027-2033) & (Million USD)
Table 103：Middle East and Africa Influenza Vaccine Market Revenue by Product Segment (2021-2026) & (Million USD)
Table 104：Middle East and Africa Influenza Vaccine Market Revenue Forecast by Product Segment (2027-2033) & (Million USD)
Table 105：Middle East and Africa Influenza Vaccine Market Revenue by Product Application (2021-2026) & (Million USD)
Table 106：Middle East and Africa Influenza Vaccine Market Revenue Forecast by Product Application (2027-2033) & (Million USD)
Table 107：Secondary Sources
Figure 1：Influenza Vaccine Product Scope
Figure 2：Global Influenza Vaccine Market Size and Growth Forecast Analysis (2021-2033) & (Million USD)
Figure 3：Global Influenza Vaccine Product Segment Market Share (2026 & 2033)
Figure 4：Global Influenza Vaccine Product Application Market Share (2026 & 2033)
Figure 5：Trivalent Influenza Vaccine Product Scope
Figure 6：Quadrivalent Influenza Vaccine Product Scope
Figure 7：6 Months to 3 Years Product Scope
Figure 8：＞ 3 Years Product Scope
Figure 9：Influenza Vaccine Industrial Chain Framework
Figure 10：Global Influenza Vaccine Market by Geographic Segmentation in 2026
Figure 11：Global Influenza Vaccine Market Share by Region (2021 VS 2026)
Figure 12：North America Influenza Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 13：North America Influenza Vaccine Revenue Market Share by Countries (2026 VS 2033)
Figure 14：U.S. Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 15：Canada Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 16：Europe Influenza Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 17：Europe Influenza Vaccine Revenue Market Share by Countries (2026 VS 2033)
Figure 18：Germany Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 19：France Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 20：United Kingdom Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 21：Italy Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 22：Spain Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 23：Benelux Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 24：China Influenza Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 25：Asia Pacific (excl. China) Influenza Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 26：Asia Pacific (excl. China) Influenza Vaccine Revenue Market Share by Countries (2026 VS 2033)
Figure 27：Japan Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 28：South Korea Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 29：India Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 30：Southeast Asia Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 31：Australia Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 32：Latin America Influenza Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 33：Latin America Influenza Vaccine Revenue Market Share by Countries (2026 VS 2033)
Figure 34：Mexico Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 35：Brazil Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 36：Middle East and Africa Influenza Vaccine Market Size and Growth Forecast (2025 VS 2026 VS 2033) & (Million USD)
Figure 37：Middle East and Africa Influenza Vaccine Revenue Market Share by Countries (2026 VS 2033)
Figure 38：Saudi Arabia Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 39：South Africa Influenza Vaccine Market Revenue and Forecast (2021-2033) & (Million USD)
Figure 40：Research Methodology
Figure 41：Primary Sources
Figure 42：Data Cross Validation
English
Related Reports 
